✦ LIBER ✦

Solvias licenses Merck

Book ID: 104384940
Publisher: Elsevier Science
Year: 2004
Weight: 59 KB
Volume: 2004
Category: Article
ISSN: 1351-4180
DOI: 10.1016/s1351-4180(04)00293-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Solvias licenses technology from Merck

📂 Article 📅 2004 🏛 Elsevier Science ⚖ 62 KB

turnover of $2005 M ($1842 M for its fiscal 2002), of which: Davison Chemicals (catalysts and silica) $1040 M ($939 M), performance chemicals $941 M ($880 M), North America $883 M ($883 M), Europe $677 M ($561 M), Asia Pacific $313 M ($269 M), and Latin America $108 M $107 M), R&D costs of $52 M ($5

Evonik and Solvias renew license agreeme

Evonik and Solvias renew license agreement

📂 Article 📅 2009 🏛 Elsevier Science ⚖ 62 KB

## BASF and Materia execute technology licence agreement Materia announced the exclusive licensing of its metathesis technology to BASF, the world's leading chemical company, for use in the R&D of certain speciality chemicals. Metathesis catalysts enable the formation and manipulation of carbon-ca

Solvias' agreements

📂 Article 📅 2005 🏛 Elsevier Science ⚖ 33 KB

Deal watch: Monoclonal antibodies target

Deal watch: Monoclonal antibodies targeting Clostridium difficile licensed to Merck

📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 125 KB

Solvias, Umicore combine

📂 Article 📅 2009 🏛 Elsevier Science ⚖ 59 KB

total campus area of approximately 60,000 sq ft. Besides a broad focus on exploring new innovative enzymes, the specific focus at the Davis site is currently on further development of the enzymes necessary for commercial production of cellulosic ethanol. The development is firmly on track and Novozy

Antaria's licenses nano Al2O3 to Merck &

Antaria's licenses nano Al2O3 to Merck & appoints Dow, Masso & IMCD to sell nano ZnO

📂 Article 📅 2009 🏛 Elsevier Science ⚖ 63 KB